Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - Orexigen Therapeutics, Inc. | Financial_Report.xls |
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER - Orexigen Therapeutics, Inc. | d268606dex321.htm |
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - Orexigen Therapeutics, Inc. | d268606dex312.htm |
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - Orexigen Therapeutics, Inc. | d268606dex311.htm |
10-K - FORM 10-K - Orexigen Therapeutics, Inc. | d268606d10k.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
(1) Registration Statements (Form S-3 Nos. 333-159015, 333-160750, and 333-161736) of Orexigen Therapeutics, Inc. and
(2) Registration Statements (Form S-8 Nos. 333-142405, 333-165442 and 333-175071) pertaining to the Orexigen Therapeutics, Inc. 2007 Equity Incentive Plan and 2004 Stock Plan;
of our reports dated March 13, 2012, with respect to the financial statements of Orexigen Therapeutics, Inc. and the effectiveness of internal control over financial reporting of Orexigen Therapeutics, Inc., included in this Annual Report (Form 10-K) of Orexigen Therapeutics, Inc. for the year ended December 31, 2011.
/s/ Ernst & Young LLP
San Diego, California
March 13, 2012